Search - tctmd.com

Displaying 281 - 300 of 406

Sort: Relevancy | Date

News Conference News SCAI 2019

TAVR Operators: Can One Do It All or Are Two Still Justified?

Yael L. Maxwell

June 04, 2019

News Conference News EuroPCR 2019

TAVR’s Benefit Across ‘Spectrum of Risk’ Supports Paradigm Shifts, Says EuroPCR Statement

Shelley Wood

May 23, 2019

Presentation EuroPCR 2019

Prosthetic valve endocarditis after transcatheter or surgical AVR with a bioprosthesis Results from the FinnValve registry

Presenter: Noriaki Moriyama

May 21, 2019

News Industry News

Pi-Cardia Successfully Completes First-in-Human Studies with Novel Non-implant Based Treatment of Aortic Stenosis

May 07, 2019

News Daily News

Public Comments Largely Supportive of CMS Plan for TAVR, With Some Suggested Tweaks

Todd Neale

May 01, 2019

News Daily News

Multisociety Consensus Statement Tackles the Classification of Heart Valve Centers

L.A. McKeown

April 19, 2019

News Daily News

Latest Observational Data Support TAVR Durability Through 7 Years

Caitlin E. Cox

April 12, 2019

Presentation SIF 2019

TAVR for Aortic Insufficiency

Presenter: Steven J Yakubov

March 30, 2019

Presentation SIF 2019

My Prediction on TAVR in Low Risk Patients

Presenter: Kendra J. Grubb

March 30, 2019

Presentation CIT 2019

Status of indication of TAVR versus SAVR in low-intermediate risk patients

Presenter: Thomas Modine

March 28, 2019

News Daily News

CMS Coverage Plan Keeps Volume Requirements for Existing TAVR Programs but Lowers Bar for New Centers

Michael O'Riordan

March 27, 2019

Presentation ACC 2019

Primary Results From the Evolut Low Risk Trial

Presenter: Michael J. Reardon

March 17, 2019

News Conference News CRT 2019

One-Year Data on Low-Risk TAVR Continue to Show Good Safety: LRT

Yael L. Maxwell

March 04, 2019

Presentation JIM 2019

When and how to perform valvuloplasty: Experience with Valver

Presenter: Nicola Corcione

February 15, 2019

News Conference News STS 2019

Redo Surgery for Bioprosthetic Aortic Valve Failure on the Decline Since 2015

Yael L. Maxwell

February 06, 2019

News Daily News

NOTION and UK TAVI Report Good Long-term Function of Transcatheter Aortic Valves

L.A. McKeown

February 06, 2019

Presentation

Durability of Transcatheter and Surgical Bioprosthetic Aortic Valves in Patients at Low Risk

February 06, 2019

Manuscript

Calcification and Thrombosis as Mediators of Bioprosthetic Valve Deterioration

February 06, 2019

News Conference News STS 2019

TAVR More Prevalent in Highly Competitive Hospital Markets

Yael L. Maxwell

February 04, 2019

News Conference News STS 2019

Past SAVR Outcomes Matter More Than Volume in Determining Future Performance

Yael L. Maxwell

January 31, 2019

Advertisement

TAVR Operators: Can One Do It All or Are Two Still Justified?

TAVR’s Benefit Across ‘Spectrum of Risk’ Supports Paradigm Shifts, Says EuroPCR Statement

Prosthetic valve endocarditis after transcatheter or surgical AVR with a bioprosthesis Results from the FinnValve registry

Pi-Cardia Successfully Completes First-in-Human Studies with Novel Non-implant Based Treatment of Aortic Stenosis

Public Comments Largely Supportive of CMS Plan for TAVR, With Some Suggested Tweaks

Multisociety Consensus Statement Tackles the Classification of Heart Valve Centers

Latest Observational Data Support TAVR Durability Through 7 Years

TAVR for Aortic Insufficiency

My Prediction on TAVR in Low Risk Patients

Status of indication of TAVR versus SAVR in low-intermediate risk patients

CMS Coverage Plan Keeps Volume Requirements for Existing TAVR Programs but Lowers Bar for New Centers

Primary Results From the Evolut Low Risk Trial

One-Year Data on Low-Risk TAVR Continue to Show Good Safety: LRT

When and how to perform valvuloplasty: Experience with Valver

Redo Surgery for Bioprosthetic Aortic Valve Failure on the Decline Since 2015

NOTION and UK TAVI Report Good Long-term Function of Transcatheter Aortic Valves

Durability of Transcatheter and Surgical Bioprosthetic Aortic Valves in Patients at Low Risk

Calcification and Thrombosis as Mediators of Bioprosthetic Valve Deterioration

TAVR More Prevalent in Highly Competitive Hospital Markets

Past SAVR Outcomes Matter More Than Volume in Determining Future Performance

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content